Senegalia modesta
Senegalia modesta · Accepted scientific name
Scientific literature: Very Sparse (4 studies) · ★☆☆☆☆
Senegalia modesta is a plant species currently under investigation for its diverse pharmacological potential, including antibacterial, anti-HIV, anticancer, and anticarcinomic activities. Scientific studies have focused on various preparations, such as aqueous extracts, methanolic extracts, and specific ethyl acetate and n-hexane fractions. Research indicates that these extracts contain bioactive compounds including lupeol, oleic acid, and squalene. These chemical constituents play a critical role in modulating biological conditions related to IL6, platelets, VEGF, and wound healing. Consequently, this species serves as a significant subject for exploring natural therapeutic interventions against complex diseases.
- Synonyms
- Senegalia Tanjorensis · Vachellia Tanjorensis · 4 more
- Common names
- Not available
- Family
- Fabaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Senegalia modesta is a versatile botanical species recognized by a diverse array of regional and descriptive names. Locally, it is frequently referred to as Phulahi, a name that distinguishes it within specific ecological contexts. In certain commercial or botanical circles, it is also known as amritsar-gum, highlighting its potential practical uses. The plant is further identified by the evocative common names black sally and blackwood, which often describe its physical appearance. Finally, it is sometimes called paloz, showcasing the many linguistic identities this single species holds.
Sources: Catalogue of Life (COL)
Synonyms
Senegalia modesta is a botanical species that has been classified under several different names throughout its taxonomic history. It is frequently identified by its synonym Acacia modesta, reflecting its close relationship to the broader acacia genus. Researchers have also categorized this plant as Acacia senegal subsp. modesta or Acacia tanjorensis in various scientific records. Furthermore, the species has been historically linked to the genus Mimosa, specifically as Mimosa dumosa and Mimosa obovata. Understanding these shifting relationships is essential for accurate identification and botanical study.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Senegalia modesta is a distinctive biological entity that belongs to the vast kingdom Plantae. Within this expansive realm, it is classified under the class Equisetopsida. It further belongs to the order Fabales, placing it among a specific group of flowering plants. As a member of the family Fabaceae, it shares characteristics with the well-known legume group. Ultimately, this species is defined by its placement within the genus Senegalia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Fabales |
| Family | Fabaceae |
| Genus | Senegalia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Senegalia modesta exhibits a wide and diverse geographical range that spans multiple climatic zones across the Asian continent. In temperate regions, the species can be found stretching through Western Asia and into Afghanistan. Its tropical presence is equally significant, particularly throughout the vast landscapes of the Indian Subcontinent. Within this subtropical expanse, the plant thrives in specific locales such as India, Nepal, and Pakistan. Furthermore, its distribution extends into the unique ecological niche of the West Himalaya, showcasing its remarkable adaptability.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Senegalia modesta is a self-supporting species characterized by its distinct tree growth form. This robust structure allows the plant to stand firmly on its own within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Senegalia modesta, also known as Acacia modesta, serves as an economically significant medicinal plant with diverse biological applications. Research indicates that this species possesses potent antibacterial and antioxidant properties, which are closely linked to its total phenolic and flavonoid content. Beyond these functions, the plant has also been evaluated for its in vitro anticancer potential. Recent studies suggest that using in vitro callus cultures can significantly enhance these beneficial antibacterial and antioxidant activities compared to standard leaf extracts. Through these specialized cultivation techniques, the therapeutic value of the plant can be maximized to overcome its naturally slow growth rate.
Compounds
Senegalia modesta, also known as Acacia modesta, has demonstrated significant therapeutic potential in treating rheumatic disorders. Through GC/MS analysis of the plant's bark, researchers identified several key medicinal compounds responsible for its biological activity. Specifically, the plant contains lupeol, which serves as a potent anti-inflammatory agent. Furthermore, the presence of oleic acid and squalene contributes to the overall medicinal profile of the species. These specific chemical constituents support the plant's ability to down-regulate pro-inflammatory biomarkers and provide immunomodulatory benefits.
Conditions
Senegalia modesta exhibits significant anti-arthritic potential by treating Complete Freund's Adjuvant-Induced Arthritis in rat models. The plant extracts effectively down-regulate the expression of pro-inflammatory biomarkers, specifically treating elevated levels of IL1β and IL6. Furthermore, the treatment demonstrates an ability to manage inflammatory processes by reducing MMP2 levels. Beyond these biochemical markers, the plant also treats hematological imbalances by normalizing Hb content. These combined actions highlight the plant's robust immunomodulatory and anti-inflammatory properties.
Preparations
Senegalia modesta is prepared as aqueous extracts to evaluate its anticancer and antibacterial potentials. The plant is also prepared as an ethyl acetate (AM-etha) fraction to investigate its effects on rheumatoid arthritis. Additionally, Senegalia modesta is prepared as a methanolic extract (AM-metha) for anti-arthritic testing. Research further involves Senegalia modesta being prepared as an n-hexane (AM-hexa) fraction to study its immunomodulatory properties. These various preparations allow for a comprehensive analysis of the plant's medicinal effectiveness against inflammatory biomarkers.